Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 5/2020

16.05.2020 | Case Report

Two cases of benign hepatic nodules caused by sinusoidal dilatation with different hemodynamics

verfasst von: Hiroya Iida, Rie Osaki, Akiko Matsubara, Hiromitsu Maehira, Haruki Mori, Takehide Fujimoto, Akira Andoh, Ryoji Kushima, Osamu Nakashima, Fukuo Kondo, Masaji Tani

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

We describe two cases of benign nodules caused by sinusoidal dilatation with different hemodynamic statuses. Case 1 was a 50-year-old woman with a 1-cm nodule that showed a low density in the arterial phase of computed tomography. Pathologically, there were no atypical cells with sinusoidal dilatation, and immunostaining was negative for CD34. We speculated that sinusoidal dilatation was caused by congestion due to loss of frequency of the central vein. In contrast, case 2 was a 50-year-old woman with a 1.5-cm nodule that was highly stained in the arterial phase of computed tomography. Although she had a sinusoidal dilatation similar to that in case 1, immunostaining was positive for CD34. Sinusoidal dilatation was thought to be caused by hyperperfusion of arterial blood. Moreover, CD34 may be potentially useful for the differentiation of the hemodynamic status.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology. 1985;5:1194–200.CrossRef Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology. 1985;5:1194–200.CrossRef
2.
Zurück zum Zitat Wanless IR. micronodular transpormation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology. 1990;11:787–97.CrossRef Wanless IR. micronodular transpormation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology. 1990;11:787–97.CrossRef
3.
Zurück zum Zitat Kondo F. Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: etiological analysis and introduction of a new concept. J Gastroenterol Hepatol. 2001;16:1319–28.CrossRef Kondo F. Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: etiological analysis and introduction of a new concept. J Gastroenterol Hepatol. 2001;16:1319–28.CrossRef
4.
Zurück zum Zitat Sherlock S, Feldman CA, Moran B, et al. Partial nodular transformation of the liver with portal hypertension. Am J Med. 1966;40:195–203.CrossRef Sherlock S, Feldman CA, Moran B, et al. Partial nodular transformation of the liver with portal hypertension. Am J Med. 1966;40:195–203.CrossRef
5.
Zurück zum Zitat Rooks JB, Ory HW, Ishak KG, et al. The association between oral contraception and hepatocellular adenoma–a preliminary report. Int J Gynaecol Obstet. 1977;15:143–4.CrossRef Rooks JB, Ory HW, Ishak KG, et al. The association between oral contraception and hepatocellular adenoma–a preliminary report. Int J Gynaecol Obstet. 1977;15:143–4.CrossRef
6.
Zurück zum Zitat Ishak KG. Hepatic lesions caused by anabolic and contraceptive steroids. Semin Liver Dis. 1981;1:116–28.CrossRef Ishak KG. Hepatic lesions caused by anabolic and contraceptive steroids. Semin Liver Dis. 1981;1:116–28.CrossRef
7.
Zurück zum Zitat Stromeyer FW, Ishak KG. Nodular transformation (nodular “regenerative” hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol. 1981;12:60–71.CrossRef Stromeyer FW, Ishak KG. Nodular transformation (nodular “regenerative” hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol. 1981;12:60–71.CrossRef
8.
Zurück zum Zitat Okuda K, Nakashima T, Okudaira M, et al. Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study. Liver. 1982;2:176–92.CrossRef Okuda K, Nakashima T, Okudaira M, et al. Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study. Liver. 1982;2:176–92.CrossRef
9.
Zurück zum Zitat Wanless IR, Albrecht S, Bilbao J, et al. Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol. 1989;2:456–62. Wanless IR, Albrecht S, Bilbao J, et al. Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol. 1989;2:456–62.
10.
Zurück zum Zitat International Working P. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22:983–93.CrossRef International Working P. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22:983–93.CrossRef
11.
Zurück zum Zitat Kondo F, Nagao T, Sato T, et al. Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension. Pathol Res Pract. 1998;194:487–95.CrossRef Kondo F, Nagao T, Sato T, et al. Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension. Pathol Res Pract. 1998;194:487–95.CrossRef
12.
Zurück zum Zitat Nguyen BN, Flejou JF, Terris B, et al. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol. 1999;23:1441–54.CrossRef Nguyen BN, Flejou JF, Terris B, et al. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol. 1999;23:1441–54.CrossRef
13.
Zurück zum Zitat Nakanuma Y, Tsuneyama K, Ohbu M, et al. Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract. 2001;197:65–76.CrossRef Nakanuma Y, Tsuneyama K, Ohbu M, et al. Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract. 2001;197:65–76.CrossRef
14.
Zurück zum Zitat Kondo F, Koshima Y, Ebara M. Nodular lesions associated with abnormal liver circulation. Intervirology. 2004;47:277–87.CrossRef Kondo F, Koshima Y, Ebara M. Nodular lesions associated with abnormal liver circulation. Intervirology. 2004;47:277–87.CrossRef
15.
Zurück zum Zitat Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–8.CrossRef Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–8.CrossRef
16.
Zurück zum Zitat Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50:481–9.CrossRef Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50:481–9.CrossRef
17.
Zurück zum Zitat Bioulac-Sage P, Cubel G, Balabaud C, et al. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis. 2011;31:91–103.CrossRef Bioulac-Sage P, Cubel G, Balabaud C, et al. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis. 2011;31:91–103.CrossRef
18.
Zurück zum Zitat Bioulac-Sage P, Balabaud C, Wanless I. Focal nodular hyperplasia and hepatocellular adenoma. In: Bosman F, Carneiro F, Hruban H, et al., editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC; 2010. p. 198–204. Bioulac-Sage P, Balabaud C, Wanless I. Focal nodular hyperplasia and hepatocellular adenoma. In: Bosman F, Carneiro F, Hruban H, et al., editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC; 2010. p. 198–204.
19.
Zurück zum Zitat Delladetsima I, Sakellariou S, Kokkori A, et al. Atrophic hepatocytes express keratin 7 in ischemia-associated liver lesions. Histol Histopathol. 2016;31:1089–94. Delladetsima I, Sakellariou S, Kokkori A, et al. Atrophic hepatocytes express keratin 7 in ischemia-associated liver lesions. Histol Histopathol. 2016;31:1089–94.
20.
Zurück zum Zitat Rush N, Sun H, Nakanishi Y, et al. Hepatic arterial buffer response: pathologic evidence in non-cirrhotic human liver with extrahepatic portal vein thrombosis. Modern Pathol. 2016;29:489–99.CrossRef Rush N, Sun H, Nakanishi Y, et al. Hepatic arterial buffer response: pathologic evidence in non-cirrhotic human liver with extrahepatic portal vein thrombosis. Modern Pathol. 2016;29:489–99.CrossRef
21.
Zurück zum Zitat Kong LJ, Li H, Du YJ, et al. Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fbrosis and sinusoidal capillarization in CCl4-induced fibrotic mice. Mol Med Rep. 2017;15:2604–10.CrossRef Kong LJ, Li H, Du YJ, et al. Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fbrosis and sinusoidal capillarization in CCl4-induced fibrotic mice. Mol Med Rep. 2017;15:2604–10.CrossRef
22.
Zurück zum Zitat Vertemati M, Petrella D, Camozzi M, et al. Histological and immunohistochemical pattern of hepatocellular carcinoma cytokeratin 7-positive and -negative: comparison by computerized morphometry. Anal Quant Cytopathol Histopathol. 2017;39:192–200. Vertemati M, Petrella D, Camozzi M, et al. Histological and immunohistochemical pattern of hepatocellular carcinoma cytokeratin 7-positive and -negative: comparison by computerized morphometry. Anal Quant Cytopathol Histopathol. 2017;39:192–200.
23.
Zurück zum Zitat Park YN, Yang CP, Fernandez GJ, et al. Neoangiogenesis and sinusoidal ‘capillarization’ in dysplastic nodules of the liver. Am J Surg Pathol. 1998;22:656–62.CrossRef Park YN, Yang CP, Fernandez GJ, et al. Neoangiogenesis and sinusoidal ‘capillarization’ in dysplastic nodules of the liver. Am J Surg Pathol. 1998;22:656–62.CrossRef
24.
Zurück zum Zitat Park YN, Kim YB, Yang KM, et al. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med. 2000;124:1061–5. Park YN, Kim YB, Yang KM, et al. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med. 2000;124:1061–5.
25.
Zurück zum Zitat Nakamura K, Zen Y, Sato Y, et al. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1α are involved in malignant transformation in dysplastic nodules of the liver. Hum Pathol. 2007;38:1532–46.CrossRef Nakamura K, Zen Y, Sato Y, et al. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1α are involved in malignant transformation in dysplastic nodules of the liver. Hum Pathol. 2007;38:1532–46.CrossRef
26.
Zurück zum Zitat Yang XR, Xu Y, Yu B, et al. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut. 2010;59:953–62.CrossRef Yang XR, Xu Y, Yu B, et al. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut. 2010;59:953–62.CrossRef
27.
Zurück zum Zitat Agostini-Vulaj D, Sharma AK, Findeis-Hosey JJ, et al. Distinction between inflammatory hepatocellular adenoma and mass effect on liver sampling. Hum Pathol. 2017;61:105–10.CrossRef Agostini-Vulaj D, Sharma AK, Findeis-Hosey JJ, et al. Distinction between inflammatory hepatocellular adenoma and mass effect on liver sampling. Hum Pathol. 2017;61:105–10.CrossRef
Metadaten
Titel
Two cases of benign hepatic nodules caused by sinusoidal dilatation with different hemodynamics
verfasst von
Hiroya Iida
Rie Osaki
Akiko Matsubara
Hiromitsu Maehira
Haruki Mori
Takehide Fujimoto
Akira Andoh
Ryoji Kushima
Osamu Nakashima
Fukuo Kondo
Masaji Tani
Publikationsdatum
16.05.2020
Verlag
Springer Singapore
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 5/2020
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-020-01129-0

Weitere Artikel der Ausgabe 5/2020

Clinical Journal of Gastroenterology 5/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.